Camillo Ricordi, M.D. is the Stacy Joy Goodman Professor and Director of the Diabetes Research Institute and the Cell Transplant Center at the University of Miami. Acknowledged as a leading scientist in diabetes and cellular therapies, Ricordi is known for inventing the method that made it possible to isolate large numbers of insulin-producing cells from the human pancreas and for performing the first series of successful clinical islet allotransplants to reverse diabetes. Two NIH funded, FDA Phase 3 multicenter trials were successfully completed, and the procedure is now used worldwide.
Ricordi’s research interests include reversal of autoimmunity, transplant tolerance, modulation of immunity and inflammation and regenerative medicine, to prevent or treat chronic degenerative disease conditions, and to prolong healthy lifespan (health span).
Ricordi and his collaborators have recently launched the program www.fit4pandemic.com to help the general population become resistant to viral pandemics, through nutrition, fitness and selected protective substances. These strategies are now also studied to prevent, or halt progression of autoimmune diseases and age related chronic degenerative conditions, to prolong healthy lifespan (Health span).
Ricordi has received numerous honors and awards, was knighted by the President of the Republic of Italy in the highest Order of the Republic (the Order of Merit), was inducted into the National Academy of Inventors, is also serving on the Supreme Council of Health (Consiglio Superiore di Sanita’) of the Ministry of Health of Italy.
Ricordi is author of over 1,150 scientific publications that have been cited over 45,700 times (H-index 102) and as an inventor, he has been awarded 27 patents.